Humacyte Inc Warrant
HUMAW
HUMAW was delisted on the 25th of August, 2026.
8 hedge funds and large institutions have $49.9K invested in Humacyte Inc Warrant in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 6 → 8 (+2)
56% less capital invested
Capital invested by funds: $113K → $49.9K (-$63.3K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.4K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$8.67K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$157 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.52K |
| 2 |
Jane Street
New York
|
-$89 |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$19 |
HUMAW Hedge Fund Activity: Q4 2025 in Review
8 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q4 2025, worth a combined $49.9K — down 56% from $113K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new HUMAW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $14.4K. The largest seller was Wolverine Asset Management, cutting an estimated $2.52K.
- 8 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q4 2025, up from 6 in Q3 2025.
- Funds reported $49.9K of Humacyte Inc Warrant stock for Q4 2025, down 56% quarter-over-quarter.
- 2 funds opened new Humacyte Inc Warrant positions in Q4 2025 and 0 closed out, a net change of +2 holders.
- The largest Humacyte Inc Warrant buyer in Q4 2025 was Susquehanna International Group, an estimated $14.4K added.
- The largest Humacyte Inc Warrant seller in Q4 2025 was Wolverine Asset Management, an estimated $2.52K sold.
Based on aggregated 13F filings for Q4 2025.